About us
Overview
mAbxience
Our Vision,
Mission, Culture
Business
Growth Story
Leadership
Team
What we do?
Biopharmaceutical
Development
Pipeline
R&D
Quality Philosophy
Manufacturing
& Supply
Commercial Supply
CDMO
mAbxience Sites
Partnerships
Media center
News
Market &
industry news
Videos
CSR
Contact us
Location
Business Development
& Licencies
Join
us
en
es
About us
Overview
mAbxience
Our Vision,
Mission, Culture
Business
Growth Story
Leadership
Team
What we do?
Biopharmaceutical
Development
Pipeline
R&D
Quality Philosophy
Manufacturing
& Supply
Commercial Supply
CDMO
mAbxience Sites
Partnerships
Media center
News
Market &
industry news
Videos
CSR
Contact us
Location
Business Development
& Licencies
Join
us
en
es
mAbxience |
Glossary
Find here all you need!
VIEW ALL
A - Z
Z - A
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
A
Active ingredient (or active substance)
ANTIBODY
ANTIGEN
ANTIGEN DETERMINANT
ANTIGENITCITY
AVIDITY
B
BACTERIOPHAGE
BACULOVIRUS
BATCH CULTURE
BINDING
BIOACTIVITY
BIOAVAILABILITY
BIOEQUIVALENCE
BIOLOGICAL DRUGS
BIOPHARMACEUTICAL
BIOPROCESSING
BioSim
BIOSIMILAR
BIOSIMILARITY
BIOTECHNOLOGY
Bispecific antibodies
C
CBER
CDMO
CELL BANK
CELL CULTURE
CELL HARVESTING
CELL LINE
cGMP
Chimeric proteins
CHIMERIC TRANSGENE
CHMP
CLINICAL STUDY TRIAL
CLONE
COMPARABILITY
E
EMA
EXTRAPOLATION
F
FDA
FEED
FINGERPRINT-LIKE
FORMULATION
Fucosylation
G
GENE TRANSFER
GENETIC ENGINEERING
GLYCOSYLATION
GMP
H
HAPTEN
HIGH-AFFINITY ANTIBODY
HLA
I
IMMUNOGENICITY
INNOVATIVE REFERENCE DRUG
INTERCHANGEABILITY
M
Mab
MANUFACTURING SCALE PRODUCTION
Marketing authorisation
MCB (MASTER CELL BANK)
MEDIA
MONOCLONAL ANTIBODY (MAB)
O
ORIGINATOR COMPANY
OUTSOURCING ACTIVITIES
P
Patent
PERFORMACE QUALIFICATION
PHARMACODYNAMIC TEST
PHARMACOKINETIC TEST
PHARMACOVIGILANCE
Q
QUALITY
R
Risk management system
S
SIMILARITY
SINGLE-USE TECHNOLOGY
SUBSTITUTION
T
TRACEABILITY